众生药业 - Financials

众生药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	2.5B	2.6B	2.7B	2.4B	1.9B
Revenue Growth %	-5.5%	-2.4%	10.2%	28.1%	--
Total Revenue	2.5B	2.6B	2.7B	2.4B	1.9B
Cost Of Revenue	1.1B	1.1B	940.0M	807.0M	657.0M
+Gross Profit	1.4B	1.5B	1.7B	1.6B	1.2B
Gross Margin %	56.0%	58.6%	64.9%	66.8%	65.3%
Total Operating Cost	2.8B	2.3B	2.4B	2.1B	2.5B
Selling Expenses	850.0M	890.0M	1.0B	941.0M	722.0M
Admin Expenses	152.0M	156.0M	172.0M	146.0M	130.0M
Rd Expenses	111.0M	127.0M	157.0M	137.0M	114.0M
Finance Expenses	8.8M	16.8M	57.2M	48.4M	9.3M
+Operating Income	-280.0M	299.0M	374.0M	313.0M	-324.0M
Operating Margin %	-11.3%	11.5%	14.0%	12.9%	-17.1%
Non Operating Income	173,000	1.2M	241,800	1.7M	511,500
Non Operating Expenses	56.1M	16.3M	6.2M	4.9M	21.6M
Investment Income	24.9M	23.5M	46.4M	20.7M	100.0M
Fair Value Change Income	-18.2M	-65.2M	-19.5M	-66.7M	138.0M
Asset Disposal Income	28,500	21.7M	14.7M	-633,000	570,100
Asset Impairment Loss	547.0M	16.7M	1.1M	7.2M	847.0M
Other Income	26.8M	20.0M	11.4M	25.0M	25.5M
Income Before Tax	-336.0M	284.0M	368.0M	309.0M	-345.0M
Income Tax	38.1M	33.8M	53.0M	34.8M	89.2M
+Net Income	-374.0M	250.0M	315.0M	275.0M	-434.0M
Net Margin %	-15.2%	9.6%	11.8%	11.3%	-22.9%
Net Income Attributable	-299.0M	263.0M	322.0M	278.0M	-427.0M
Minority Interest	-74.8M	-13.4M	-6.7M	-3.0M	-7.8M
Eps Basic	-0.36	0.32	0.40	0.35	-0.53
Eps Diluted	-0.36	0.32	0.40	0.35	-0.53

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.4B	1.3B	928.0M	1.0B	1.3B
Trading Financial Assets	306.0M	683.0M	341.0M	240.0M	307.0M
Accounts Receivable	533.0M	481.0M	502.0M	493.0M	403.0M
Notes Receivable	466.0M	498.0M	702.0M	299.0M	553.0M
Notes And Accounts Receivable	1.0B	978.0M	1.2B	792.0M	956.0M
Prepayments	84.2M	87.3M	88.0M	97.6M	94.9M
Inventory	441.0M	520.0M	481.0M	452.0M	404.0M
Total Current Assets	3.5B	4.0B	3.2B	2.7B	3.1B
Long Term Equity Investment	2.4M	1.8M	4.3M	78.0M	77.9M
Fixed Assets	--	569.0M	549.0M	539.0M	535.0M
Fixed Assets Total	658.0M	569.0M	549.0M	539.0M	535.0M
Construction In Progress	--	124.0M	82.0M	56.5M	23.0M
Construction In Progress Total	27.6M	124.0M	82.0M	56.5M	23.0M
Intangible Assets	327.0M	447.0M	260.0M	261.0M	268.0M
Long Term Deferred Expenses	1.4M	3.4M	5.9M	6.7M	232,400
Total Non Current Assets	2.1B	2.5B	2.5B	2.2B	1.6B
Total Assets	5.6B	6.5B	5.8B	4.9B	4.8B
Short Term Borrowings	303.0M	621.0M	588.0M	190.0M	481.0M
Accounts Payable	71.6M	84.8M	109.0M	107.0M	88.8M
Advance Receipts	52,600	--	4.1M	--	35,700
Contract Liabilities	20.1M	25.9M	45.2M	18.9M	26.0M
Total Current Liabilities	1.2B	1.0B	1.1B	524.0M	820.0M
Long Term Borrowings	--	97.0M	286.0M	308.0M	225.0M
Total Non Current Liabilities	340.0M	918.0M	850.0M	840.0M	330.0M
Total Liabilities	1.5B	1.9B	2.0B	1.4B	1.1B
Paid In Capital	852.0M	853.0M	814.0M	814.0M	814.0M
Capital Reserve	1.8B	1.8B	1.3B	1.3B	1.5B
Surplus Reserve	322.0M	322.0M	303.0M	270.0M	248.0M
Retained Earnings	915.0M	1.4B	1.3B	1.2B	1.1B
Minority Equity	95.3M	169.0M	114.0M	62.5M	102.0M
Equity Attributable	3.9B	4.4B	3.7B	3.5B	3.5B
Total Equity	4.0B	4.5B	3.8B	3.5B	3.6B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	2.3B	2.4B	2.2B	2.7B	1.8B
Tax Refunds Received	4.4M	22.5M	20.0M	29.0M	15.4M
Total Operating Cash Inflow	2.5B	2.6B	2.3B	2.8B	1.9B
Cash Paid For Goods	635.0M	800.0M	675.0M	617.0M	520.0M
Cash Paid To Employees	250.0M	239.0M	219.0M	211.0M	180.0M
Taxes Paid	230.0M	238.0M	227.0M	261.0M	234.0M
Total Operating Cash Outflow	2.2B	2.4B	2.2B	2.2B	1.8B
Operating Cash Flow	338.0M	191.0M	63.1M	623.0M	139.0M
Total Investing Cash Inflow	1.6B	430.0M	158.0M	202.0M	758.0M
Total Investing Cash Outflow	1.2B	1.2B	685.0M	887.0M	555.0M
Investing Cash Flow	385.0M	-743.0M	-527.0M	-685.0M	204.0M
Cash From Borrowings	302.0M	1.3B	1.1B	400.0M	944.0M
Dividends And Interest Paid	171.0M	172.0M	181.0M	187.0M	196.0M
Debt Repayments	722.0M	1.0B	581.0M	606.0M	659.0M
Total Financing Cash Inflow	343.0M	2.1B	1.1B	602.0M	1.0B
Total Financing Cash Outflow	905.0M	1.2B	765.0M	847.0M	857.0M
Financing Cash Flow	-562.0M	842.0M	358.0M	-244.0M	159.0M
Net Change In Cash	160.0M	289.0M	-103.0M	-307.0M	503.0M
Ending Cash Balance	1.4B	1.2B	912.0M	1.0B	1.3B
Capex	228.0M	363.0M	268.0M	214.0M	154.0M